Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMNP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,837
Award facts
- Contract value 100% obligated
- $7,837.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $7,837.33 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 1, 2025, with an ultimate completion date of December 2, 2025, was issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract that DMS Pharmaceutical Group secured on November 13, 2025. The PPV-G GEN V represents a $30.3 billion government-wide acquisition strategy designed to consolidate pharmaceutical supply chains for the Department of Defense, and DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (IDC) with a $499.999 billion ceiling through December 31, 2036. No set-aside designation was used for this particular delivery order.
Under this delivery order, DMS Pharmaceutical Group supplies pharmaceutical products and medical consumables to support federal military healthcare operations, drawing from its extensive portfolio that includes branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and over-the-counter drugs. The company's established performance across numerous delivery orders issued by the DLA Medical Supply Chain division demonstrates its capability to fulfill the diverse pharmaceutical requirements of Department of Defense healthcare facilities. As a critical supplier within the federal pharmaceutical supply chain since 2001, DMS Pharmaceutical Group leverages its small business status and registered System for Award Management designation to compete and perform effectively across the government's military medical supply network.
Quick answers
Who was awarded contract SPE2DU26FEMNP?
SPE2DU26FEMNP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DU26FEMNP worth?
The government has obligated $7,837 on SPE2DU26FEMNP.
Is contract SPE2DU26FEMNP an order under another contract?
Yes. SPE2DU26FEMNP is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMNP competed?
The extent of competition for SPE2DU26FEMNP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award